CRSP vs ONC
CRISPR Therapeutics AG · BeOne Medicines AG
Relative return (rebased to 100)
Key stats
| Metric | CRSP | ONC |
|---|---|---|
| Price | $55.79 | $358.26 |
| Market Cap | $5.39B | $529.55B |
| P/E | — | 1845.56 |
| P/B | 3.09 | 102.35 |
| P/S | 1536.89 | 99.11 |
| ROE | -33.3% | 5.5% |
| Net Margin | -16569.8% | 5.4% |
| Gross Margin | — | 87.5% |
| Revenue Growth | -90.6% | 40.2% |
| Dividend Yield | — | — |
| EPS | -$6.01 | $0.19 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.